0028

Tiansheng Pharmaceutical Group Co., Ltd. (002872)

Market Closed
12 Dec, 06:57
XSHE XSHE
¥
4. 84
-0.05
-1.02%
¥
1.67B Market Cap
- P/E Ratio
0.63% Div Yield
3,122,100 Volume
- Eps
¥ 4.89
Previous Close
Day Range
4.82 5.07
Year Range
3.47 5.81
Want to track 002872 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002872 closed yesterday lower at ¥4.84, a decrease of 1.02% from Thursday's close, completing a monthly decrease of -4.72% or ¥0.24. Over the past 12 months, 002872 stock gained 8.76%.
002872 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, missed the consensus estimates by -0.04%. On average, the company has fell short of earnings expectations by -0.05%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).

002872 Chart

Similar

Wuhan Tianyu Information Industry Co., Ltd.
¥ 4.33
-1.37%
Shenzhen Guohua Network Co. Ltd.
¥ 10.91
-3.79%
Suzhou Goldengreen Technologies Ltd.
¥ 4.61
-1.91%
Wafangdian Bearing Co., Ltd.
2.83 HKD
-0.7%
Thomson Reuters China Biomed ETF
¥ -
-

Tiansheng Pharmaceutical Group Co., Ltd. (002872) FAQ

What is the stock price today?

The current price is ¥4.84.

On which exchange is it traded?

Tiansheng Pharmaceutical Group Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002872.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.63%.

What is its market cap?

As of today, the market cap is 1.67B.

Has Tiansheng Pharmaceutical Group Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Tiansheng Pharmaceutical Group Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Shuang Liu CEO
XSHE Exchange
CNE100002QC3 ISIN
CN Country
1,272 Employees
- Last Dividend
22 Aug 2018 Last Split
- IPO Date

Overview

Tiansheng Pharmaceutical Group Co., Ltd., established in 2001 and headquartered in Chongqing, China, operates in the pharmaceutical sector with a broad engagement in manufacturing and circulation activities. The company has developed a robust portfolio, delivering a wide range of healthcare solutions across various medical fields. Its commitment to health and wellbeing is reflected in its extensive product offerings, catering to multiple therapeutic areas and patient needs.

Products and Services

Tiansheng Pharmaceutical Group Co., Ltd. offers a diversified selection of products and services across multiple healthcare categories, including:

  • Respiratory: Products targeting diseases and conditions affecting the respiratory system, such as asthma and chronic obstructive pulmonary disease (COPD), aiming to improve patients' breathing and overall lung health.
  • Digestive: Solutions designed to address various digestive system issues, from common ailments such as indigestion and constipation to more complex conditions like irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD).
  • Cardiovascular and Cerebrovascular: Medications and treatments focusing on heart and brain blood vessel health, helping to prevent and manage conditions like hypertension, stroke, and heart disease.
  • Pediatric: A range of healthcare products tailored for children, addressing pediatric health needs from preventive vaccines to treatments for acute and chronic illnesses.
  • Gynecological: Specialized treatments and healthcare products targeting women's health issues, including reproductive health, menopause symptoms, and gynecological infections.
  • Orthopedic: Solutions aimed at supporting bone health, joint mobility, and the treatment of musculoskeletal conditions such as osteoporosis and arthritis.
  • Oncology: Comprehensive cancer care products, including chemotherapy agents and supportive care medicines, aimed at treating various types of cancer and mitigating treatment side effects.
  • Hepatobiliary: Treatments focused on liver and bile duct health, addressing conditions such as hepatitis, liver cirrhosis, and gallstones.
  • Blood: Products designed for the management of blood disorders and conditions, including anemia and clotting disorders, ensuring better hemodynamic health.
  • Surgery: A selection of pharmaceuticals and medical products supporting surgical procedures, including anesthetics, wound care, and post-operative recovery products.
  • Diabetes: Medications and management solutions for diabetes, aiming to regulate blood sugar levels, prevent complications, and promote overall wellness in diabetic patients.

Contact Information

Address: Chaoyang Industrial Park, Chongqing, China, 408300
Phone: 86 23 7469 5513